Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

Amplify Weight Loss Drug & Treatment ETF

This ETF provides exposure to Equities

THNR performance and flow charts

Last update 7/17/2026 at 1:30 PM
Live
Closed
Last price
$25.72
-$0.11 (-0.41%) 7/17/2026

Performance

0246810%Jun 17Jun 25Jul 2Jul 10Jul 17

Flows

0200,000400,000600,000800,000
1 day price range
$25.67
$25.81
52 week price range
$21.94
$26.73
1W perf
-0.74%
YTD perf
+1.99%
YTD flows
+$2M
AuM
$5M
E/R
0.59%
TTM yield
1.61%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of July 17, 2026
1M3MYTD1Y3Y5Y
Perf.+5.75%+2.78%+1.99%+14.21%
Flows+$769K+$769K+$2M+$2M--
Data as of July 17, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The Amplify Weight Loss Drug & Treatment ETF is built to track the VettaFi Weight Loss Drug & Treatment Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderAmplify ETFs
N° of holdings20
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateMay 21, 2024
ESGNo
TrackinsightTrackinsight

More data and info about THNR on Trackinsight

Exposure

Data as of May 31, 2026

Diversification

90.83%

Total weight of top 15 holdings out of 20

Top 15 Holdings

Novo Nordisk A/S
14.39%
Eli Lilly & Co.
13.48%
Arrowhead Pharmaceuticals, Inc.
6.19%
Amgen, Inc.
6.02%
Regeneron Pharmaceuticals, Inc.
5.6%
Chugai Pharmaceutical Co., Ltd.
5.24%
Roche Holding AG
5.15%
Merck & Co., Inc.
5.05%
Innovent Biologics, Inc.
4.88%
AstraZeneca PLC
4.76%
Pfizer Inc.
4.7%
AbbVie, Inc.
4.63%
Shionogi & Co., Ltd.
4.18%
CSPC Pharmaceutical Group Ltd.
4.09%
Scholar Rock Holding Corp.
2.47%

Sectors

Healthcare
98.8%
Other
1.2%

Countries

USA
51.87%
Denmark
16.32%
China
10.1%
Japan
9.42%
Other
12.29%
Advertisement

Trading data

Last sale
7/17/2026 at 1:30 PM
$25.72
Previous close
$25.83
Consolidated volume
07/16/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+19.59%+18.10%
Max drawdown
-5.40%-12.38%
Max drawdown duration
67d160dN/AN/A
Time to recover
58d106dN/AN/A

Replication quality

Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about THNR

What type of ETF is THNR?

THNR is a Passive ETF that provides exposure to Equity assets. It is managed by Amplify ETFs.

What index does THNR track?

THNR tracks the VettaFi Weight Loss Drug & Treatment Index - USD, aiming to replicate its performance through full replication.

What does THNR invest in?

This ETF provides exposure to Equities. It is part of the segment: Tomorrow's Treatments.

What is the expense ratio of THNR?

The total expense ratio (TER) of THNR is 0.59%, representing the annual fee charged by the fund manager.

When was THNR launched?

THNR was launched on May 21, 2024, marking its entry into the ETF market.

Who is the issuer of THNR?

THNR is issued by Amplify ETFs.

What is the AUM of THNR?

As of July 17, 2026, THNR manages $5.14 M, reflecting the total assets held in the fund.

How has THNR performed recently?

As of July 17, 2026, THNR delivered a return of 5.75% over the past month (1M performance), 2.78% over the past three months (3M), and 1.99% year-to-date (YTD).

What are the recent fund flows for THNR?

As of July 17, 2026, THNR has seen net flows of +$769K in the past month (1M flow) and +$2M year-to-date (YTD).

Does THNR pay dividends?

As of July 17, 2026, THNR has a trailing 12-month distribution yield of 1.61%.

How many holdings are in THNR

As of May 31, 2026, THNR holds 20 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is THNR?

As of May 31, 2026, THNR holds 20 securities, with 90.83% of its assets concentrated in its top 15 holdings.

What are the top holdings of THNR?

As of May 31, 2026, THNR holds a portfolio of 20 underlyings, with its largest positions including Novo Nordisk A/S, Eli Lilly & Co. and Arrowhead Pharmaceuticals, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does THNR invest in?

As of May 31, 2026, THNR has its largest geographic exposures in USA, Denmark and China.

What sectors or themes does THNR focus on?

As of May 31, 2026, THNR is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 13, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 14, 2026
First Look ETF: Cash Deployment, Bond, and Hedged ETFs

First Look ETF

First Look ETF: Cash Deployment, Bond, and Hedged ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · July 10, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 6, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 7, 2026
The ETF Show - The Evolution of Leveraged & Inverse ETFs

Asset TV

The ETF Show - The Evolution of Leveraged & Inverse ETFs

Leveraged and inverse ETFs have exploded in popularity over the past decade capturing more assets as retail traders seek to capture volatility.

Asset TV
By Asset TV · July 3, 2026

Browse all educational columns

Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder